EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic breast
 

Despite the fact that the incidence of cancer is many fold higher in persons over 65 years of age, we still have an inadequate understanding on how best to treat these older cancer patients. Furthermore, even though elderly patients are occasionally included in clinical trials, those elderly patients who are eventually included are mostly 'healthy' (fit) elderly patients.

More...

Re: EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic bre
 

Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1



http://clinicaltrials.gov/show/NCT01597414

60 or older, or below 60 with "dependencies"